Journal
BIOMARKERS IN MEDICINE
Volume 9, Issue 10, Pages 1025-1040Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/bmm.15.69
Keywords
biomarker; HbA(1C); miRNA; pancreatic beta-cell; Type 2 diabetes mellitus
Categories
Funding
- Ramalingaswami fellowship (Department of Biotechnology - DBT, Government of India) [BT/RLF/Re-entry/11/2012]
- Savitribai Phule Pune University Research and Development
- Indian Institute of Science Education and Research, Pune
- DBT, India
Ask authors/readers for more resources
Type 2 diabetes mellitus (T2DM) has reached epidemic proportions and is associated with peripheral insulin resistance. The currently used therapies aim to delay progression of T2DM. Their efficacy could drastically be improved if implemented at earlier stages. Classical diagnostic markers (blood glucose and HbA(1C)) are generally detected once metabolic imbalance has already set in. Therefore, development of biomarkers for early diagnosis would help identify individuals at risk for developing T2DM. Along with genetic predisposition, epigenetics also plays a major role in T2DM development. In this review, we discuss the potential role of early diagnostic markers such as circulating miRNAs, studies done so far and challenges to be considered while taking into account the novel role of miRNAs as prognostic biomarkers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available